What's new in chickenpox (varicella-zoster) infection?

Por Gershon, A A
Publicado em 1993

Vaccination to prevent zoster in the elderly

Por GERSHON, A. A.
Publicado em 2007

Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Por Steinberg, S P, Gershon, A A
Publicado em 1991

Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.

Por Gershon, A A, Steinberg, S P
Publicado em 1981

Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Por Gershon, A A, Steinberg, S P
Publicado em 1979

Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

Por Gershon, A A, Steinberg, S P
Publicado em 1979

Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

Por Gershon, A A, Steinberg, S, Smith, M
Publicado em 1976

Antibody to varicella-zoster virus after passive immunization against chickenpox.

Por Gershon, A A, Piomelli, S, Karpatkin, M, Smithwick, E, Steinberg, S
Publicado em 1978

Cholesterol Dependence of Varicella-Zoster Virion Entry into Target Cells

Por Hambleton, S., Steinberg, S. P., Gershon, M. D., Gershon, A. A.
Publicado em 2007

Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Por Preissner, C M, Steinberg, S P, Gershon, A A, Smith, T F
Publicado em 1982

Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin.

Por Zhu, Z, Gershon, M D, Ambron, R, Gabel, C, Gershon, A A
Publicado em 1995

Targeting of glycoprotein I (gE) of varicella-zoster virus to the trans-Golgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecul...

Por Zhu, Z, Hao, Y, Gershon, M D, Ambron, R T, Gershon, A A
Publicado em 1996

Population diversity in batches of the varicella Oka vaccine

Por Kanda, R.K., Quinlivan, M.L., Gershon, A.A., Nichols, R.A., Breuer, J.
Publicado no Vaccine (2011)

Envelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi network.

Por Zhu, Z, Gershon, M D, Hao, Y, Ambron, R T, Gabel, C A, Gershon, A A
Publicado em 1995

Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.

Por Gabel, C A, Dubey, L, Steinberg, S P, Sherman, D, Gershon, M D, Gershon, A A
Publicado em 1989

Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.

Por Gershon, A A, Sherman, D L, Zhu, Z, Gabel, C A, Ambron, R T, Gershon, M D
Publicado em 1994

The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antib...

Por MAPLE, P. A. C., HAEDICKE, J., QUINLIVAN, M., STEINBERG, S. P., GERSHON, A. A., BROWN, K. E., BREUER, J.
Publicado no Epidemiol Infect (2016)

Comparative Study of the Standard Fluorescent Antibody to Membrane Antigen (FAMA) Assay and a Flow Cytometry-Adapted FAMA Assay To Assess Immunity to Varicella-Zoster Virus

Por Lafer, M. M., Weckx, L. Y., de Moraes-Pinto, M. I., Garretson, A., Steinberg, S. P., Gershon, A. A., LaRussa, P. S.
Publicado em 2011

Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers

Por McDonald, S.L.R., Maple, P.A.C., Andrews, N., Brown, K.E., Ayres, K.L., Scott, F.T., Bassam, M. Al, Gershon, A.A., Steinberg, S.P., Breuer, J.
Publicado no J Virol Methods (2010)